Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.6400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots26.6400/ 2
- Ask / Lots27.5000/ 2
- Open / Previous Close0.0000 / 26.6400
- Day Range---
- 52 Week Range
- Volume102
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 29285 | 26.51 |
| 09:34 ET | 3811 | 26.5338 |
| 09:36 ET | 2936 | 26.43 |
| 09:38 ET | 15170 | 26.44 |
| 09:39 ET | 5969 | 26.3599 |
| 09:41 ET | 8439 | 26.29 |
| 09:43 ET | 1550 | 26.31 |
| 09:45 ET | 5013 | 26.435 |
| 09:48 ET | 5505 | 26.51 |
| 09:50 ET | 3697 | 26.525 |
| 09:52 ET | 6433 | 26.52 |
| 09:54 ET | 2565 | 26.55 |
| 09:56 ET | 9637 | 26.5 |
| 09:57 ET | 4290 | 26.47 |
| 09:59 ET | 12619 | 26.53 |
| 10:01 ET | 8060 | 26.49 |
| 10:03 ET | 6981 | 26.5 |
| 10:06 ET | 3186 | 26.47 |
| 10:08 ET | 4114 | 26.4 |
| 10:10 ET | 3552 | 26.385 |
| 10:12 ET | 5165 | 26.3643 |
| 10:14 ET | 900 | 26.36 |
| 10:15 ET | 8159 | 26.41 |
| 10:17 ET | 3704 | 26.405 |
| 10:19 ET | 3051 | 26.415 |
| 10:21 ET | 4870 | 26.4 |
| 10:24 ET | 2849 | 26.35 |
| 10:26 ET | 4751 | 26.35 |
| 10:28 ET | 3995 | 26.32 |
| 10:30 ET | 850 | 26.31 |
| 10:32 ET | 6208 | 26.305 |
| 10:33 ET | 707 | 26.3139 |
| 10:35 ET | 4239 | 26.31 |
| 10:37 ET | 5324 | 26.325 |
| 10:39 ET | 1459 | 26.325 |
| 10:42 ET | 4548 | 26.355 |
| 10:44 ET | 800 | 26.35 |
| 10:46 ET | 9439 | 26.35 |
| 10:48 ET | 6356 | 26.375 |
| 10:50 ET | 13135 | 26.325 |
| 10:51 ET | 9847 | 26.295 |
| 10:53 ET | 67192 | 26.3325 |
| 10:55 ET | 5939 | 26.3025 |
| 10:57 ET | 5990 | 26.325 |
| 11:00 ET | 33953 | 26.39 |
| 11:02 ET | 15771 | 26.39 |
| 11:04 ET | 8014 | 26.39 |
| 11:06 ET | 4020 | 26.395 |
| 11:08 ET | 4206 | 26.4 |
| 11:09 ET | 4289 | 26.405 |
| 11:11 ET | 965 | 26.405 |
| 11:13 ET | 4076 | 26.425 |
| 11:15 ET | 1347 | 26.425 |
| 11:18 ET | 4502 | 26.44 |
| 11:20 ET | 2437 | 26.44 |
| 11:22 ET | 15643 | 26.485 |
| 11:24 ET | 3917 | 26.51 |
| 11:26 ET | 4920 | 26.53 |
| 11:27 ET | 2572 | 26.55 |
| 11:29 ET | 1169 | 26.55 |
| 11:31 ET | 3691 | 26.53 |
| 11:33 ET | 2636 | 26.5856 |
| 11:36 ET | 1909 | 26.5867 |
| 11:38 ET | 2696 | 26.575 |
| 11:40 ET | 3847 | 26.585 |
| 11:42 ET | 400 | 26.58 |
| 11:44 ET | 1000 | 26.595 |
| 11:45 ET | 1396 | 26.585 |
| 11:47 ET | 2371 | 26.5899 |
| 11:49 ET | 1000 | 26.58 |
| 11:51 ET | 3300 | 26.555 |
| 11:54 ET | 9722 | 26.5595 |
| 11:56 ET | 1855 | 26.56 |
| 11:58 ET | 1830 | 26.56 |
| 12:00 ET | 2460 | 26.525 |
| 12:02 ET | 700 | 26.52 |
| 12:03 ET | 100 | 26.515 |
| 12:05 ET | 8565 | 26.5099 |
| 12:07 ET | 16918 | 26.5162 |
| 12:09 ET | 2103 | 26.5 |
| 12:12 ET | 4018 | 26.52 |
| 12:14 ET | 10745 | 26.505 |
| 12:16 ET | 2930 | 26.545 |
| 12:18 ET | 24613 | 26.56 |
| 12:20 ET | 3930 | 26.57 |
| 12:21 ET | 5105 | 26.58 |
| 12:23 ET | 2717 | 26.575 |
| 12:25 ET | 1806 | 26.61 |
| 12:27 ET | 4213 | 26.65 |
| 12:30 ET | 5513 | 26.67 |
| 12:32 ET | 5135 | 26.6398 |
| 12:34 ET | 1337 | 26.635 |
| 12:36 ET | 1957 | 26.63 |
| 12:38 ET | 8209 | 26.6 |
| 12:39 ET | 3104 | 26.62 |
| 12:41 ET | 1300 | 26.615 |
| 12:43 ET | 1730 | 26.595 |
| 12:45 ET | 1388 | 26.595 |
| 12:48 ET | 3052 | 26.59 |
| 12:50 ET | 5672 | 26.62 |
| 12:52 ET | 7902 | 26.595 |
| 12:54 ET | 1002 | 26.585 |
| 12:56 ET | 9107 | 26.61 |
| 12:57 ET | 2261 | 26.6 |
| 12:59 ET | 543 | 26.6 |
| 01:01 ET | 3683 | 26.575 |
| 01:03 ET | 2529 | 26.56 |
| 01:06 ET | 480 | 26.56 |
| 01:08 ET | 2402 | 26.575 |
| 01:10 ET | 1302 | 26.565 |
| 01:12 ET | 2500 | 26.56 |
| 01:14 ET | 2704 | 26.575 |
| 01:15 ET | 600 | 26.575 |
| 01:17 ET | 2317 | 26.58 |
| 01:19 ET | 661 | 26.5798 |
| 01:21 ET | 3183 | 26.57 |
| 01:24 ET | 1706 | 26.565 |
| 01:26 ET | 8274 | 26.569 |
| 01:28 ET | 2217 | 26.57 |
| 01:30 ET | 6083 | 26.56 |
| 01:32 ET | 4131 | 26.58 |
| 01:33 ET | 2033 | 26.6001 |
| 01:35 ET | 4686 | 26.6 |
| 01:37 ET | 2258 | 26.6 |
| 01:39 ET | 3212 | 26.595 |
| 01:42 ET | 1529 | 26.6 |
| 01:44 ET | 5377 | 26.56 |
| 01:46 ET | 3189 | 26.56 |
| 01:48 ET | 8102 | 26.56 |
| 01:50 ET | 8608 | 26.58 |
| 01:51 ET | 1468 | 26.565 |
| 01:53 ET | 1757 | 26.575 |
| 01:55 ET | 22934 | 26.56 |
| 01:57 ET | 4422 | 26.525 |
| 02:00 ET | 1724 | 26.525 |
| 02:02 ET | 4753 | 26.525 |
| 02:04 ET | 2444 | 26.54 |
| 02:06 ET | 4293 | 26.57 |
| 02:08 ET | 800 | 26.57 |
| 02:09 ET | 800 | 26.57 |
| 02:11 ET | 8606 | 26.5499 |
| 02:13 ET | 4558 | 26.56 |
| 02:15 ET | 8811 | 26.56 |
| 02:18 ET | 612 | 26.565 |
| 02:20 ET | 3200 | 26.57 |
| 02:22 ET | 2374 | 26.575 |
| 02:24 ET | 5503 | 26.58 |
| 02:26 ET | 139281 | 26.5 |
| 02:27 ET | 456 | 26.51 |
| 02:29 ET | 2721 | 26.505 |
| 02:31 ET | 23192 | 26.485 |
| 02:33 ET | 7828 | 26.485 |
| 02:36 ET | 4385 | 26.475 |
| 02:38 ET | 430 | 26.475 |
| 02:40 ET | 2467 | 26.49 |
| 02:42 ET | 3887 | 26.515 |
| 02:44 ET | 1947 | 26.5 |
| 02:45 ET | 1401 | 26.505 |
| 02:47 ET | 2812 | 26.505 |
| 02:49 ET | 6711 | 26.535 |
| 02:51 ET | 1688 | 26.54 |
| 02:54 ET | 998 | 26.53 |
| 02:56 ET | 5289 | 26.535 |
| 02:58 ET | 2592 | 26.5497 |
| 03:00 ET | 500 | 26.545 |
| 03:02 ET | 9766 | 26.53 |
| 03:03 ET | 1293 | 26.52 |
| 03:05 ET | 5376 | 26.495 |
| 03:07 ET | 3353 | 26.505 |
| 03:09 ET | 3453 | 26.515 |
| 03:12 ET | 733 | 26.52 |
| 03:14 ET | 5524 | 26.495 |
| 03:16 ET | 13168 | 26.52 |
| 03:18 ET | 14680 | 26.53 |
| 03:20 ET | 2322 | 26.515 |
| 03:21 ET | 800 | 26.515 |
| 03:23 ET | 9329 | 26.5 |
| 03:25 ET | 19703 | 26.56 |
| 03:27 ET | 4476 | 26.57 |
| 03:30 ET | 4334 | 26.565 |
| 03:32 ET | 2876 | 26.57 |
| 03:34 ET | 1210 | 26.575 |
| 03:36 ET | 18849 | 26.58 |
| 03:38 ET | 5611 | 26.59 |
| 03:39 ET | 3924 | 26.5972 |
| 03:41 ET | 14329 | 26.565 |
| 03:43 ET | 5673 | 26.56 |
| 03:45 ET | 63800 | 26.55 |
| 03:48 ET | 8788 | 26.595 |
| 03:50 ET | 11497 | 26.605 |
| 03:52 ET | 13836 | 26.64 |
| 03:54 ET | 14296 | 26.665 |
| 03:56 ET | 23214 | 26.66 |
| 03:57 ET | 28510 | 26.635 |
| 03:59 ET | 67070 | 26.64 |
Yesterday
May 22, 2024
DJ Cytokinetics Falls 10% on Royalty Pharma Transaction, Stock Offer, from 4:35PM ET on Wednesday May 22, 2024 by Dow Jones
4:35PM ET on Wednesday May 22, 2024 by Dow JonesRoyalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:10PM ET on Wednesday May 22, 2024 by Dow Jones
4:10PM ET on Wednesday May 22, 2024 by Dow JonesCytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:00PM ET on Wednesday May 22, 2024 by Dow Jones
4:00PM ET on Wednesday May 22, 2024 by Dow Jones
May 17, 2024
DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones
7:31AM ET on Friday May 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 15.9B | 14.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.0x | --- |
Catalent Inc | 9.8B | -8.3x | --- |
Jazz Pharmaceuticals PLC | 6.6B | 21.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.1x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.9B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.15% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.9x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
